Overview A Canadian medical cannabis revolution
Established in 2017, GlassHouse Botanics is a privately owned and operated Licensed Producer of medicinal cannabis sitting on 23 acres of pristine land in the Ottawa Valley, an hour and half from Ottawa Canada. As described below, the GlassHouse facility is the greenhouse of the future with over 43,000 square feet of hybrid greenhouse and head-house. Soon the facility will be EU-GMP certified to enable GlassHouse to provide it’s medicinal products to the European market.
Past
The idea of GlassHouse originally started when one of our co-founders, Dan Tauvette, started researching the benefits of cannabis and the potential of the cannabis plant a number of years ago. The more he researched, the greater his certainty of the substantial medicinal applications. His research lead him to the realization that so many people could benefit from the plant- from cancer patients to people with pain, stress and anxiety.
The main motivation for our other founder, Jeff Black, comes from his desire to make a difference in the lives of people suffering from a number of ailments and conditions. This passion came from the suffering he watched his young daughter, Lael, go through for 3 ½ years. Lael was 6 years old when she was diagnosed with stage four Rhabdomyosarcoma – a very rare childhood cancer. Forty weeks of chemotherapy was the only treatment available. The pain and suffering a 6-year-old must go through each day, week and month is something no child should ever have to endure, and no parent should ever have to helplessly standby and watch. The anti-nausea and pain medication prescribed did very little if anything to stop the daily suffering. When the chemo stopped working Lael went through various other drug trials which eventually also failed to stop or slow the cancer. In 2008, when she was just 10 years of age, receiving radiation and morphine to control the pain, she passed away. In those last months of her life she suffered severe pain as the cancer grew in different areas of her little body. No palliative treatments were ever very effective in reducing her pain except for morphine, which, due to the level required, really didn’t allow her to have much of a life at all. With more, targeted research and development, cannabis may become far more effective in reducing nausea in cancer patients or for pain reduction and management with far less harmful side effects than that of morphine or other addictive opioids that are commonly prescribed. Jeff’s hope is that Cannabis can some day reduce some of the suffering people like Lael endure every day.
Present
Since receiving our cultivation and processing license from Health Canada in July 2019 we have been extremely busy hiring and training outstanding team members, planting and cloning thousands of seeds and plants, defoliating, feeding and just watching our beautiful healthy plants grow! We have over 30,000 plants at various stages of their life cycle in our greenhouses and mother room while at the same time we are working hard to keep our facility spotlessly clean. Since December 2019 we have a cloning and harvesting event almost every week!
Future
Just like our greenhouses, our future looks very bright! With a solid team that is expanding daily, over 30,000 of lush, full, robust plants and a harvest every week, 2020 is already turning out to be an amazing year. Our plans for the year include licensing 11 acres of our property for an outdoor grow by the summer and obtaining EU-GMP certification by the Fall to order to commence selling our medicinal products in the European market to pharmacies and their patients. We’re thrilled to continue to develop as a company and discover new products for our customers around the world as we drive to be a leader in the medicinal cannabis space. The future is limitless. Join us on the journey!
Present
Since receiving our cultivation and processing license from Health Canada in July 2019 we have been extremely busy hiring and training outstanding team members, planting and cloning thousands of seeds and plants, defoliating, feeding and just watching our beautiful healthy plants grow! We have over 30,000 plants at various stages of their life cycle in our greenhouses and mother room while at the same time we are working hard to keep our facility spotlessly clean. Since December 2019 we have a cloning and harvesting event almost every week!
Construction Phase 1 – Canada
Construction seems so long ago. We Broke ground in May 2018 and worked tirelessly through all the changes (as you can see below) until we finally received our Health Canada license in July 2019.
Our TeamWe’re just getting started
Our team is made up of a perfect blend of business, science and agricultural backgrounds. And like our plants, we’re growing. See our careers page for more information about job opportunities.
Dan Tauvette
Co-FounderDan Tauvette Co-Founder
As the original visionary of Glasshouse, Dan joined forces with Jeff Black to create a state-of-the-art cannabis production operation with its sole goal of producing pure quality that is trusted and desired world-wide.
Dan has brought his vision into reality literally from the ground up by overseeing and being hands-on throughout the construction phase of the Glasshouse facility to the growing and nurturing of the living and breathing cannabis plants.
As demonstrated in Dan’s previous life as owner and operator of Tauvette Construction, his entrepreneurial spirit and competitive personality drives him to take on and master new projects and challenges. He has a deep-rooted desire to always improve and raise the bar for himself and others around him to create a successful outcome whatever the task at hand may be.
Jeff Black
Co-Founder and CEOJeff Black Co-Founder and CEO
After 20 years as a partner with Deloitte, one of the largest accounting firms in the world, leading divisions, offices and geographic regions for the Firm, Jeff teamed up with Dan Tauvette to assure Glasshouse success. Jeff’s professionalism, client service expertise and strong leadership skills developed over years of providing quality service to Deloitte clients will serve Glasshouse and their customers well.
As the CFO for the Glasshouse group of companies and CEO of the European operations, Jeff’s role is to ensure overall market and financial success of Glasshouse.
Jeff is very proactive and creative when it comes to the high-level direction of the company as well as hands-on when dealing with the day-to-day activities of Glasshouse market place activities and financial operations. This is the main reason why Jeff relocated to Malta; to be closer to the fastest growing medicinal cannabis market in the world.
Karen Power
CFOKaren Power CFO
Karen joined Glasshouse’s leadership team in January 2019 as Vice President of Finance & Tax. Karen is responsible for all internal and external financial reporting for both the Canadian and European operations. She ensures compliance with Canadian and International filing requirements while assisting Jeff with the development of global tax strategies.
Karen was previously Vice President of Tax at Modern Niagara, one of Canada’s largest institutional and commercial construction contractors. While her role started as a purely tax function, after the departure of Modern’s corporate controller, Karen took on the corporate controller role and became responsible for the consolidated accounting and financial functions. Her expanded role included the preparation of forecasts, annual preparation of the consolidated budgets, assisting in the preparation of quarterly tax projections and annual tax return preparation.
Prior to joining Modern Niagara, Karen was a Tax Partner in Deloitte’s National Capital Region. In her practice with Deloitte, Karen provided tax compliance and planning services for a wide range of clients. She assisted clients in corporate reorganization and restructurings including mergers, acquisitions, business disposition including specific shareholder planning. She provided shareholders and senior executives with compensation, and tax strategies to minimize personal and estate taxes.
Mariana Black
QAP, Health & Safety OfficerMariana Black QAP, Health & Safety Officer
As QAP of Glasshouse Botanics, Mariana is responsible for the overall quality, safety and compliance of our products to all our markets. Mariana is in charge of implementing and maintaining our Quality Management System to meet Health Canada regulations and EU Good Manufacturing Practices guidelines.
In addition to performing QA duties, Mariana manages Glasshouse Botanics’ Occupational Health & Safety Program.
Before becoming Glasshouse QAP, Mariana was Safety Manager at BC Tree Fruits Cooperative where she managed the On-Farm Food Safety Program for over 400 tree and vine fruit growers and managed the food safety and OHS programs for 9 facilities, including a cidery and 4 packing houses. Prior to this position, Mariana had different roles with food manufacturing facilities needing to implement and certify their food safety and quality systems. She also worked as Food Safety Analyst for a provincial government helping companies implement food safety programs and training industry on internal auditing and food safety systems.
Andrew Desjardins
VP of OperationsAndrew Desjardins VP of Operations
Brennan Hieblinger
Head GrowerBrennan Hieblinger Head Grower
As Master Grower of Glasshouse Botanics, Brennan works closely with QAP, ensuring all cultivation procedures adhere to Health Canada regulations and EU Good Manufacturing Practices.
With several years experience cultivating for Licensed Producers, as well working closely with companies building and expanding their facilities, Brennan applies his knowledge by ensuring from beginning to end, all cultivation practices are optimal and understood by all glasshouse botanics cultivators.
Brennan has had a unique opportunity to grow alongside the Canadian cannabis industry. From hands on experience building greenhouses, changing legislation from MMAR, ACMPR, and the Cannabis Act, to experience with many growing methods such as soils to hydroponics, Brennan takes pride in sharing what he has learned, and understands the importance of always looking for new ways to improve.
Coleman Lappe
Assistant Head GrowerColeman Lappe Assistant Head Grower
Our Greenhouse – The Differentiator
Our facility is something special. From the outside it looks like 3 large, new greenhouses with crystal clear walls and ceilings. But once you see what’s inside you begin to appreciate that it is so much more. They are greenhouses from the future!
They still have all the advantages of most top of the line greenhouses where the plants can bathe in the rich natural powers of the sun and grow the way plants were always meant to grow while protected from the harsh outside elements when it gets nasty outside. But then technology takes over to bring our greenhouses into the twenty first century and beyond. The lights, shades, temperature and humidity are all dynamically controlled by its environment. Any changes in the outside weather, such as the temperature rising or dropping a few degrees, humidity or the barometric pressure changing, the wind picking up or changing direction, cloud building up, rain pouring down or the sun coming out – will cause the environmental controls in the greenhouse to dynamically adjust to those changes in the outside conditions to ensure they have no effect on the perfectly balanced environment inside the greenhouse. This is the greenhouse of the future and it is here in our facility.
Europe
With over 742 million people in Europe where half of the European countries have legalized medical cannabis and the other half considering legalizing medicinal cannabis, the current and future demand for high quality medicinal cannabis is greater than any other country in the world. The barriers to entry in Europe are also high as all cannabis must be produced in an EU-GMP certified facility in order for it to enter the EU. This strict criteria reduces the sources of supply that are available for the consumer. GlassHouse is working towards EU-GMP certification so that it is able to supply the much needed medicinal cannabis to Europe by the fall of 2020.
